Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Healthcare technology company Philips announced that it is investing more than $150 million in U.S. manufacturing and ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Insulin Market to exceed US$ 31.5 Bn by 2035, expanding at 4.1% CAGR, driven by rising diabetes prevalence and growing access to advanced ...

Wall Street braced for results from retail giants as rising concerns over inflation cloud the path to an interest rate cut.

The global monoclonal antibody therapeutics market is set to witness a growth rate of ~12% in the next 5 years. Rising ...

Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) missed Wall Street’s revenue expectations in Q2 CY2025, with ...

The company is shifting some production from China and Mexico in a move that could soften the impact of tariffs.

Global Insulin-Sensitizing Agents Market to Reach USD 22.1 Billion by 2025, Growing at 5% CAGR Through 2032 The global Insulin-Sensitizing Agents Market is poised for steady expansion, projected to ...

Ascendis Pharma's TransCon platform shows promise, but challenges with rollout, competition, and execution risks lead to a ...